Emergent Biosolutions Inc (EBS)
Cost of Revenue
$389.70M
TTM · Period ending: · USD
EBS Cost of Revenue
Latest reported$389.70Mperiod ending
Latest reported$389.70Mperiod ending
EBS TTM Cost of Revenue ($485.70M → $389.70M)
TTM cost of revenue
High-resolution chart · PNG
EBS cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 389,700,000 | |
| 376,000,000 | |
| 393,200,000 | |
| 349,300,000 | |
| 376,900,000 | |
| 613,700,000 | |
| 667,600,000 | |
| 716,800,000 | |
| 765,300,000 | |
| 659,600,000 | |
| 688,600,000 | |
| 797,100,000 | |
| 807,800,000 | |
| 814,200,000 | |
| 827,400,000 | |
| 907,100,000 | |
| 984,500,000 | |
| 1,040,300,000 | |
| 989,200,000 | |
| 921,000,000 | |
| 859,200,000 | |
| 760,200,000 | |
| 728,500,000 | |
| 633,900,000 | |
| 590,900,000 | |
| 577,900,000 | |
| 596,800,000 | |
| 626,400,000 | |
| 571,300,000 | |
| 516,600,000 | |
| 462,100,000 | |
| 384,015,000 | |
| 343,977,000 | |
| 294,152,000 | |
| 277,149,999 | |
| 258,210,999 | |
| 258,696,999 | |
| 255,879,999 | |
| 238,776,000 | |
| 223,329,000 | |
| 226,000,000 | |
| 209,989,000 | |
| 216,845,000 | |
| 238,366,000 | |
| 245,577,000 | |
| 276,138,000 | |
| 268,829,000 | |
| 246,059,000 | |
| 218,429,000 | |
| 193,744,000 | |
| 181,325,000 | |
| 186,745,000 | |
| 175,365,000 | |
| 141,328,000 | |
| 112,417,000 | |
| 72,645,000 | |
| 45,731,000 | |
| 48,614,000 | |
| 42,171,000 | |
| 44,841,000 | |
| 45,667,000 | |
| 40,674,000 | |
| 47,114,000 | |
| 41,898,000 | |
| 39,050,000 | |
| 38,402,000 | |
| 46,262,000 | |
| 41,350,000 | |
| 43,185,000 | |
| 41,439,000 | |
| 34,081,000 | |
| 44,755,000 | |
| 45,643,000 | |
| 42,803,000 | |
| 40,309,000 | |
| 35,245,000 | |
| 27,720,000 | |
| 21,878,000 | |
| 16,362,000 | |
| 3,882,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 167,300,000 | |
| 270,500,000 | |
| 405,400,000 | |
| 485,700,000 | |
| 485,700,000 |